Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 15Genitourinary 9Head & Neck 5Gastrointestinal 5Thoracic 4Other 4Lymphoid 4Plasma cell 3Gynecologic 3Dermatologic 3Other hematologic neoplasm 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Myeloid 1CNS 1

Conditions

Neoplasms 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sugars × Tumor-Agnostic × Clear all
NCT01238120 2021-05-05

The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients

University of Rochester

Phase 2 Completed
110 enrolled 15 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡